Sundrug Co.,Ltd. (TYO:9989)
4,796.00
+41.00 (0.86%)
Aug 8, 2025, 3:30 PM JST
Sundrug Revenue
In the fiscal year ending March 31, 2025, Sundrug had annual revenue of 801.81B JPY with 6.66% growth. Sundrug had revenue of 198.22B in the quarter ending March 31, 2025, with 6.68% growth.
Revenue
801.81B
Revenue Growth
+6.66%
P/S Ratio
0.70
Revenue / Employee
112.22M
Employees
7,145
Market Cap
560.98B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 801.81B | 50.03B | 6.66% |
Mar 31, 2024 | 751.78B | 61.32B | 8.88% |
Mar 31, 2023 | 690.46B | 41.73B | 6.43% |
Mar 31, 2022 | 648.73B | 14.42B | 2.27% |
Mar 31, 2021 | 634.31B | 16.54B | 2.68% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.22B |
Takeda Pharmaceutical Company | 4,480.25B |
HOYA Corporation | 876.09B |
Daiichi Sankyo Company | 1,924.68B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |